Literature DB >> 2117303

Therapy for gonococcal infections: options in 1989.

J S Moran1, J M Zenilman.   

Abstract

The choice of therapy for Neisseria gonorrhoeae infections is complicated by antibiotic resistance and by the varying efficacy of some antibiotics at different anatomic sites of infection. Ceftriaxone (a single intramuscular dose of 250 mg) is a simple, effective, and generally well-tolerated choice for uncomplicated N. gonorrhoeae infection at all anatomic sites. Alternatives include single-dose oral regimens of ciprofloxacin, norfloxacin, and cefuroxime axetil as well as single-dose intramuscular regimens of spectinomycin, ceftizoxime, and cefotaxime. The addition of doxycycline (100 mg orally twice a day for 7 days) is recommended for presumptive treatment of chlamydial coinfection. Tetracyclines should not be used as sole therapy for gonococcal infection because of gonococcal resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117303     DOI: 10.1093/clinids/12.supplement_6.s633

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  13 in total

Review 1.  Antibiotic treatment of gonorrhoea--clinical evidence for choice.

Authors:  C Bignell
Journal:  Genitourin Med       Date:  1996-10

2.  Need for treatment of gonorrhea to be effective against Chlamydia trachomatis.

Authors:  W R Bowie; J Ast; L Sibau; C Shaw; H D Jones; W A Black
Journal:  Can J Infect Dis       Date:  1993-11

Review 3.  The value of new antimicrobial agents.

Authors:  J H Wagenvoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

Review 4.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 5.  Quinolones in sexually transmitted diseases.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

7.  Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Côte d'Ivoire: assessment of efficacy and cost.

Authors:  G La Ruche; F Lorougnon; N Digbeu
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

8.  Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  P C Fuchs; A L Barry; C Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  In vitro activity of temafloxacin compared with those of other agents against 100 clinical isolates of Neisseria gonorrhoeae.

Authors:  A E Glatt; M Cummings; W McCormack
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

10.  Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.

Authors:  J M Zenilman; T Neumann; M Patton; C Reichart
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.